BridgeBio is a biopharmaceutical company dedicated to discovering, developing, and delivering transformative medicines for patients living with genetic diseases and genetically defined cancers. Since our founding in 2015, we have built a diverse portfolio of more than 20 drug development programs, ranging from early discovery to late-stage clinical trials, across multiple therapeutic areas including precision oncology, cardiology, endocrinology, neurology, and renal disease. We have already achieved regulatory approval for three therapies and continue to advance promising science from academia into meaningful treatments for patients worldwide.
BridgeBio is a global biotechnology company with our Global Headquarters located in San Francisco, USA, and our International HQ located in Zug, Switzerland. Since establishing our European presence in 2021, we’ve been building empowered, high-performing teams across countries — with experienced colleagues who move quickly, take ownership, and are fueling the company’s international growth.
At BridgeBio, you’ll find an energetic and collaborative culture where pragmatism meets bold decision-making. We embrace uncertainty with confidence, guided by our commitment to making a meaningful impact for patients. Our people are trusted and empowered, united by urgency, purpose, and the drive to advance science for patients around the world.
To learn more about our story and company culture, visit us at https://bridgebio.com
You will report to the General Manager, Europe Central Region and work closely with local Market Access, and regional and global Medical Affairs to drive strategic initiatives that support BridgeBio’s mission of delivering transformative medicines to patients with genetic diseases and genetically driven cancers.
Your primary purpose will be to set up and lead our Medical Affairs team, develop and oversee execution of our country medical affairs plan from early pre-launch through post-launch, ensure medical and scientific education of HCPs as part of our launch efforts, and support market access related work as a key stakeholder. You will also be a core member of the extended International Medical Affairs team, bringing the voice of the country to the international discussion and decision-making process.
This role requires effective collaboration with cross-functional colleagues and external stakeholders to ensure high-quality execution and impact. The ideal candidate combines deep expertise in medical and scientific engagement in the context of introducing a biotech for the first time to KOLs, and making a remarkable contribution to a disease space in pre-launch and launch phase in a rare disease and orphan condition. We look for strong communication skills, adaptability, and the ability to thrive in a fast-paced, hands-on environment.
The above job description documents the general nature and level of work but is not intended to be an exhaustive list of activities, duties, and responsibilities required of job incumbents. Therefore, job incumbents are expected to perform all other duties as assigned or required, as training and experience allow.
This is a Germany-based role with a strong customer facing component. We anticipate travel within Germany (focus) for KOL meetings and speaker program attendance, Austria, Switzerland (for internal alignment and engagement at our international office in Zug) and European travel for conference attendance, KOL meetings and speaker program attendance. Local team meetings and designated office location in Germany is Munich.
We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.
BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 20+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs. Our focus on scientific excellence and rapid execution aim to translate today’s discoveries into tomorrow’s medicines. We have U.S. offices in San Francisco, Palo Alto, and Raleigh, with small satellites in other parts of the country. We also have international offices in Montreal, Canada, and Zurich, Switzerland, and are expanding across Europe. To learn more about our story and company culture, visit us at https://bridgebio.com
Please mention you found this job on AI Jobs. It helps us get more startups to hire on our site. Thanks and good luck!
Understand the required skills and qualifications, anticipate the questions you may be asked, and study well-prepared answers using our sample responses.
Senior Director Q&A's